Lazarus Howard
Chief Medical Officer
Lazarus Howard has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2026.
On the most recent filing, Lazarus Howard is listed as Chief Medical Officer at Avalyn Pharma Inc. Inside the rolling window, Lazarus Howard reported no open-market purchases and 1 open-market sale totaling $371K in AVLN.
Companies traded
Other insiders at AVLN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$371K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lazarus Howard made?
Lazarus Howard has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Lazarus Howard trade?
Lazarus Howard has filed SEC Form 4 disclosures for 1 company, including AVLN.
When was Lazarus Howard's most recent SEC Form 4 filing?
Lazarus Howard's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2026.
What is Lazarus Howard's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lazarus Howard is listed as Chief Medical Officer.
What is Lazarus Howard's total buy and sell value in the current window?
Inside the rolling retention window, Lazarus Howard bought $0 and sold $371K based on SEC Form 4 filings.
What was Lazarus Howard's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,300 AVLN shares on 2026-11-17, worth $371K, per SEC Form 4 filings.